Mortality and safety during follow-up
myocardial infarction
HYPERNATREMIA, SECONDARY, MYOCARDIAL INFARCTION
Vital status at Day 60 and safety outcomes are described in Table Occurrence of primary and secondary outcomes(#) RRT: Renal-replacement therapyForty-five (3.3%) patients presented at least one episode of hypernatremia > 155 mmol/L, and 14 (1.0%) had an episode of mesenteric or myocardial infarction during follow-up.